Staphylococcus epidermidis KH 11 is a human pathogen that was isolated from infected catheter tip.
human pathogen Bacteria| @ref 20215 |
Last LPSN update
2026-05-29 08:28:18 |
| Domain Bacteria |
| Phylum Bacillota |
| Class Bacilli |
| Order Caryophanales |
| Family Staphylococcaceae |
| Genus Staphylococcus |
| Species Staphylococcus epidermidis |
| Full scientific name Staphylococcus epidermidis (Winslow and Winslow 1908) Evans 1916 (Approved Lists 1980) |
| Synonyms (1) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 1344 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive  | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 1344 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water |
| @ref | Growth | Type | Temperature (°C) | |
|---|---|---|---|---|
| 1344 | positive | growth | 37 |
| Test 1 | |
|---|---|
| @ref | 1344 |
| Medium | Mueller-Hinton Agar |
| Manual annotation | 1 |
| Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 24-26 |
| Ampicillin 10µg (disc) | 28 |
| Aztreonam 30µg (disc) | 0 |
| Bacitracin 10Unit | 16-18 |
| Cefalotin 30µg (disc) | 38 |
| Cefazolin 30µg (disc) | 32 |
| Cefotaxime 30µg (disc) | 32 |
| Ceftriaxone 30µg (disc) | 30-32 |
| Chloramphenicol 30µg (disc) | 10-12 |
| Clindamycin 10µg (disc) | 36-38 |
| Colistin 10µg (disc) | 8 |
| Doxycycline 30µg (disc) | 26 |
| Erythromycin 15µg (disc) | 30-32 |
| Fosfomycin 50µg (disc) | 40 |
| Gentamicin 10µg (disc) | 28 |
| Imipenem 10µg (disc) | 50 |
| Kanamycin 30µg (disc) | 12-14 |
| Lincomycin 15µg (disc) | 32-34 |
| Linezolid 10µg (disc) | 32-34 |
| Mezlocillin 30µg (disc) | 24-26 |
| Moxifloxacin 5µg (disc) | 34 |
| Neomycin 30µg (disc) | 10 |
| Nitrofurantoin 100µg (disc) | 28 |
| Norfloxacin 10µg (disc) | 32 |
| Nystatin 100Unit | 0 |
| Ofloxacin 5µg (disc) | 30 |
| Oxacillin 5µg (disc) | 36 |
| Penicillin G 6µg (disc) | 24 |
| Pipemidic acid 20µg (disc) | 20-22 |
| Piperacillin/Tazobactam 40µg (disc) | 32 |
| Polymyxin B 300Unit | 10-12 |
| Quinupristin/Dalfopristin 15µg (disc) | 30 |
| Teicoplanin 30µg (disc) | 16 |
| Tetracycline 30µg (disc) | 28 |
| Ticarcillin 75µg (disc) | 30 |
| Vancomycin 30µg (disc) | 20 |
| 1344 | Compoundslime |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68375 | 22599 ChEBI | arabinose | - | fermentation | from API ID32STA |
| 68375 | 29016 ChEBI | arginine | + | hydrolysis | from API ID32STA |
| 68375 | 17057 ChEBI | cellobiose | - | fermentation | from API ID32STA |
| 68375 | 15824 ChEBI | D-fructose | + | fermentation | from API ID32STA |
| 68375 | 17634 ChEBI | D-glucose | + | fermentation | from API ID32STA |
| 68375 | 16899 ChEBI | D-mannitol | - | fermentation | from API ID32STA |
| 68375 | 16024 ChEBI | D-mannose | + | fermentation | from API ID32STA |
| 68375 | 16988 ChEBI | D-ribose | - | fermentation | from API ID32STA |
| 68375 | 4853 ChEBI | esculin | - | hydrolysis | from API ID32STA |
| 68375 | 17716 ChEBI | lactose | + | fermentation | from API ID32STA |
| 68375 | 17306 ChEBI | maltose | + | fermentation | from API ID32STA |
| 68375 | 17632 ChEBI | nitrate | + | reduction | from API ID32STA |
| 68375 | 18257 ChEBI | ornithine | - | degradation | from API ID32STA |
| 68375 | 16634 ChEBI | raffinose | - | fermentation | from API ID32STA |
| 68375 | 17992 ChEBI | sucrose | + | fermentation | from API ID32STA |
| 68375 | 27082 ChEBI | trehalose | - | fermentation | from API ID32STA |
| 68375 | 32528 ChEBI | turanose | + | fermentation | from API ID32STA |
| 68375 | 16199 ChEBI | urea | + | hydrolysis | from API ID32STA |
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|
| 1344 | 161680 | Aztreonam | 30 µg (disc) | from Antibiotic test | |
| 1344 | 7660 | Nystatin | 100 Unit | from Antibiotic test |
| @ref | Chebi-ID | Metabolite | Production | |
|---|---|---|---|---|
| 68375 | 15688 ChEBI | acetoin | from API ID32STA |
| @ref | Chebi-ID | Metabolite | Voges-proskauer-test | |
|---|---|---|---|---|
| 68375 | 15688 ChEBI | acetoin | + | from API ID32STA |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68375 | alkaline phosphatase | + | 3.1.3.1 | from API ID32STA |
| 68375 | arginine dihydrolase | + | 3.5.3.6 | from API ID32STA |
| 68375 | beta-galactosidase | - | 3.2.1.23 | from API ID32STA |
| 68375 | beta-glucosidase | - | 3.2.1.21 | from API ID32STA |
| 68375 | beta-glucuronidase | - | 3.2.1.31 | from API ID32STA |
| 68375 | L-arginine arylamidase | - | from API ID32STA | |
| 68375 | ornithine decarboxylase | - | 4.1.1.17 | from API ID32STA |
| 68375 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API ID32STA |
| 68375 | urease | + | 3.5.1.5 | from API ID32STA |
| @ref | URE | ADH (Arg) | ODC | ESC | GLU | FRU | MNE | MAL | LAC | TRE | MAN | RAF | RIB | CEL | Reduction of nitrateNIT | Acetoin production (Voges Proskauer test)VP | beta GAL | L-arginine arylamidaseArgA | PAL | Pyrrolidonyl arylamidasePyrA | NOVO | SAC | NAG | TUR | ARA | beta GUR | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1344 | + | + | - | - | + | + | + | + | + | - | - | - | - | - | + | + | - | - | + | - | - | + | - | + | - | - | |
| 1344 | + | + | - | - | + | + | + | + | + | - | - | - | - | - | + | + | - | - | + | - | + | + | + | + | - | - |
Phages| @ref | Name | Strain number | |
|---|---|---|---|
| 124042 | Staphylococcus phage vB_SepM_Alex | DSM 3269 |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| A new method for testing non-porous surfaces for their antimicrobial efficacy using an aerosol-generating spray chamber. | Poelzl S, Dreisiebner D, Zarschenas E, Nokhbehzaeim R, Kittinger C. | Front Microbiol | 10.3389/fmicb.2024.1508596 | 2024 | | |
| Proof-of-Concept Standardized Approach Using a Single-Disk Method Analogous to Antibiotic Disk Diffusion Assays for Routine Phage Susceptibility Testing in Diagnostic Laboratories. | Skusa R, Gross J, Kohlen J, Schafmayer C, Ekat K, Podbielski A, Warnke P. | Appl Environ Microbiol | 10.1128/aem.00309-22 | 2022 | | |
| Identification and Characterization of Corynaridin, a Novel Linaridin from Corynebacterium lactis. | Pashou E, Reich SJ, Reiter A, Weixler D, Eikmanns BJ, Oldiges M, Riedel CU, Goldbeck O. | Microbiol Spectr | 10.1128/spectrum.01756-22 | 2023 | | |
| Identification of Bacteria Associated with Post-Operative Wounds of Patients with the Use of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Approach. | Szultka-Mlynska M, Janiszewska D, Pomastowski P, Zloch M, Kupczyk W, Buszewski B. | Molecules | 10.3390/molecules26165007 | 2021 | | |
| Thiazolidin-4-Ones as a Promising Scaffold in the Development of Antibiofilm Agents-A Review. | Trotsko N. | Int J Mol Sci | 10.3390/ijms25010325 | 2023 | | |
| Pathogenicity | Effects of selenium coating of orthopaedic implant surfaces on bacterial adherence and osteoblastic cell growth. | Holinka J, Pilz M, Kubista B, Presterl E, Windhager R. | Bone Joint J | 10.1302/0301-620x.95b5.31216 | 2013 | |
| Development of An Impedimetric Aptasensor for the Detection of Staphylococcus aureus. | Reich P, Stoltenburg R, Strehlitz B, Frense D, Beckmann D. | Int J Mol Sci | 10.3390/ijms18112484 | 2017 | | |
| Enzymology | Does Extracellular DNA Production Vary in Staphylococcal Biofilms Isolated From Infected Implants versus Controls? | Zatorska B, Groger M, Moser D, Diab-Elschahawi M, Lusignani LS, Presterl E. | Clin Orthop Relat Res | 10.1007/s11999-017-5266-0 | 2017 | |
| Antimicrobial and antiproliferative activity of Athamanta sicula L. (Apiaceae). | Stefano VD, Pitonzo R, Schillaci D. | Pharmacogn Mag | 10.4103/0973-1296.75893 | 2011 | | |
| Pathogenicity | Defensins from the tick Ixodes scapularis are effective against phytopathogenic fungi and the human bacterial pathogen Listeria grayi. | Tonk M, Cabezas-Cruz A, Valdes JJ, Rego RO, Chrudimska T, Strnad M, Sima R, Bell-Sakyi L, Franta Z, Vilcinskas A, Grubhoffer L, Rahnamaeian M. | Parasit Vectors | 10.1186/s13071-014-0554-y | 2014 | |
| Enzymology | In vivo and in vitro studies of antibiotic release from and bacterial growth inhibition by antibiotic-impregnated polymethylmethacrylate hip spacers. | Kelm J, Regitz T, Schmitt E, Jung W, Anagnostakos K. | Antimicrob Agents Chemother | 10.1128/aac.50.1.332-335.2006 | 2006 | |
| Chemistry and biology of essential oils of genus boswellia. | Hussain H, Al-Harrasi A, Al-Rawahi A, Hussain J. | Evid Based Complement Alternat Med | 10.1155/2013/140509 | 2013 | | |
| Antiplasmodial Activity Is an Ancient and Conserved Feature of Tick Defensins. | Cabezas-Cruz A, Tonk M, Bouchut A, Pierrot C, Pierce RJ, Kotsyfakis M, Rahnamaeian M, Vilcinskas A, Khalife J, Valdes JJ. | Front Microbiol | 10.3389/fmicb.2016.01682 | 2016 | | |
| Pathogenicity | Cold atmospheric air plasma sterilization against spores and other microorganisms of clinical interest. | Klampfl TG, Isbary G, Shimizu T, Li YF, Zimmermann JL, Stolz W, Schlegel J, Morfill GE, Schmidt HU. | Appl Environ Microbiol | 10.1128/aem.00583-12 | 2012 | |
| Antimicrobial potential and osteoblastic cell growth on electrochemically modified titanium surfaces with nanotubes and selenium or silver incorporation. | Staats K, Pilz M, Sun J, Boiadjieva-Scherzer T, Kronberger H, Tobudic S, Windhager R, Holinka J | Sci Rep | 10.1038/s41598-022-11804-6 | 2022 | | |
| Pathogenicity | Zirconium Nitride Coating Reduced Staphylococcus epidermidis Biofilm Formation on Orthopaedic Implant Surfaces: An In Vitro Study. | Pilz M, Staats K, Tobudic S, Assadian O, Presterl E, Windhager R, Holinka J | Clin Orthop Relat Res | 10.1097/CORR.0000000000000568 | 2019 | |
| Pathogenicity | Antimicrobial and antistaphylococcal biofilm activity from the sea urchin Paracentrotus lividus. | Schillaci D, Arizza V, Parrinello N, Di Stefano V, Fanara S, Muccilli V, Cunsolo V, Haagensen JJ, Molin S | J Appl Microbiol | 10.1111/j.1365-2672.2009.04394.x | 2010 | |
| Pathogenicity | In vitro anti-biofilm activity of Boswellia spp. oleogum resin essential oils. | Schillaci D, Arizza V, Dayton T, Camarda L, Di Stefano V | Lett Appl Microbiol | 10.1111/j.1472-765X.2008.02469.x | 2008 | |
| Pathogenicity | Granulocyte colony-stimulating factor for the treatment of biomaterial-associated staphylococcal infections in-vitro. | Schlobe A, Schnitzler N, Schweizer K, Rohde D | Urol Res | 10.1007/s00240-002-0289-7 | 2002 | |
| Metabolism | Evidence for degradation of synthetic polyurethanes by Staphylococcus epidermidis. | Jansen B, Schumacher-Perdreau F, Peters G, Pulverer G | Zentralbl Bakteriol | 10.1016/s0934-8840(11)80216-1 | 1991 | |
| Pathogenicity | Anticoagulant properties of extracellular slime substance produced by Staphylococcus epidermidis. | Bykowska K, Ludwicka A, Wegrzynowicz Z, Lopaciuk S, Kopec M | Thromb Haemost | 1985 | | |
| Pathogenicity | In vitro activity of fosfomycin in combination with various antistaphylococcal substances. | Grif K, Dierich MP, Pfaller K, Miglioli PA, Allerberger F | J Antimicrob Chemother | 10.1093/jac/48.2.209 | 2001 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive14523.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License